Invokana

Invokana Indications/Uses

canagliflozin

Manufacturer:

Janssen-Cilag

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Monotherapy and combination therapy: INVOKANA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
INVOKANA is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus who have established cardiovascular disease (CVD) or at least two risk factors for CVD.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in